| Pharmaceutical active ingredients: |
| Moxisylyte Hydrochloride |
| Available forms, composition and doses of Uroalpha: |
| N / A |
| Uroalpha medical category: |
| Human:Alpha1-adrenergic antagonistsErectile dysfunction treatment drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C04AX10 - MoxisylyteG04BE06 - Moxisylyte |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Fournier |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Uro Furan | Nitrofurantoin | Bunker Industria Farmaceutica |
| Uro Gantanol | Phenazopyridine Hydrochloride; Sulfamethoxazole | Roche |
| Uro Heractrim | Phenazopyridine; Sulfamethoxazole; Trimethoprim | Herald's do Brasil |
| Uro Hubber | Chymotrypsin; Erythromycin Estolate; Nitrofurantoin; Scopolamine Methobromide; Tetracycline Hydrochloride; Trypsin | Valeant Pharmaceuticals; ICN Pharmaceuticals |
| Uro Septoprin | Phenazopyridine; Sulfamethoxazole; Trimethoprim | Medley Industria Farmaceutica |
| Uroalquine | Citric Acid Anhydrous; Potassium Citrate; Sodium Citrate | Rider Laboratorios |
| Uroazulen | Guaiazulene | Unidentified Pharmaceutical Company |
| Urobac | Nitrofurantoin | Sanofi-Aventis |
| Urobacid | Norfloxacin | Novartis; Biochemie; F.P. Marketing; IDS Group; Medical Supplies, Malaysia; Sandoz; Svizera Healthcare; Tyrol Pharma |
| Urobactam | Aztreonam | Bristol-Myers Squibb |